Fingerprint
Dive into the research topics of 'Carfilzomib 56 mg/m2 twice-weekly in combination with dexamethasone and daratumumab (KdD) versus daratumumab in combination with bortezomib and dexamethasone (DVd): a matching-adjusted indirect treatment comparison'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically